Gautam Mukunda, lecturer at the Yale School of Management and Bloomberg Opinion columnist, warns that the artificial intelligence industry is not prepared for potential catastrophic risks, particularly biological ones. A Microsoft study published in October 2025 reveals that AI-generated DNA sequences evade commercial detection tools nearly two-thirds of the time, with only a 32% success rate. Current synthetic DNA screening relies largely on voluntary participation, creating significant gaps in security. In June 2026, major AI leaders including Sam Altman and Demis Hassabis signed an open letter urging Congress to impose mandatory screening measures, but no comprehensive federal legislation has yet been passed in the United States.
Source: Read the original article
